A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic Cancer
Clinical trial NCT04975061 · UNKNOWN
Trial details
- NCT number
- NCT04975061
- Sponsor
- Shanghai YingLi Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-01
- Primary completion
- 2022-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.